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HIV seroconversion during pregnancy in the Tygerberg 
region of Cape Town
G B Theron, J Schoeman, E Carolus
To the Editor: AIDS is one of the leading causes of death 
in children, with mother-to-child-transmission being the 
dominant mode of HIV acquisition among young children. A 
high viral load is associated with a higher risk of transmission.1 
Seroconversion during pregnancy results in viraemia and high 
viral load.  
    The current Perinatal Maternal to Child Transmission 
(PMTCT) programme in the Western Cape provides voluntary 
counselling and testing at the booking visit.  Women who 
become HIV-positive during pregnancy do not receive 
prophylaxis during labour, as they are believed to be HIV-
negative. Especially at risk are women who book early, 
increasing the interval between testing and delivery. These 
women will also not receive counselling on the best method 
of infant feeding, increasing the HIV risk. Repeat HIV testing 
during late pregnancy will identify these cases.  However, 
before extending additional resources to retest during 
pregnancy the extent of the problem needs to be verified.2
   Consecutive HIV-negative women tested before 24 weeks’ 
gestation at antenatal clinics in the Tygerberg region were 
approached to take part in the study between 36 and 38 weeks 
of pregnancy. Patients who accepted repeat testing received 
pre-test counselling and gave signed informed consent 
followed by HIV rapid testing and post-test counselling. Five 
hundred patients were recruited, with the sample size at 
each site proportionate to the clinic size. The OraQuick Rapid 
Test (OraShure Technologies, Bethlehem, Penn., USA) was 
used for screening and the Pareekshak HIV Tri-Line (BHAT 
Bio-Tech, Bangalore, India) for confirmation. In the event of 
discordance an enzyme-linked immunosorbent assay (ELISA) 
was performed.
   A total of 532 patients were recruited from February to 
September 2004; 524 (98.5%) consented to a second test (Table 
I). The mean age of the study patients at the sites ranged from 
22.9 to 29.3 years, the median gravidity from 1 to 2 and the 
proportion of primigravidas from 14.4% to 62.4%.  The mean 
gestational age at the first antenatal visit ranged from 15.9 
to 18.4 weeks and at retesting from 36.7 to 38.1 weeks.  The 
percentage of patients who declined screening at the first visit 
ranged from 4.9% to 20.3%, and the HIV seropositive rate 
ranged from 0.9% to 16.7% (Table I) according to PMTCT data 
collected from January to June 2004. No patient seroconverted 
during pregnancy. One discordant rapid test occurred, but the 
ELISA test was negative.
   The seroconversion rate in the Tygerberg region appears to 
be lower than the 5% reported at Chris Hani Baragwanath 
Hospital (Rwakvendela et al., unpublished data, 2002) and the 
2.2% reported at King Edward VIII Hospital3 following the 
retesting of 390 and 191 patients, respectively.  Retesting during 
late pregnancy could be restricted to women with high-risk 
behaviour.
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Table I. Characteristics of clinics included in the study
  HIV pre-  Declined test 
Clinic N valence (%) at booking (%)
Tygerberg Hospital   53   8.7    4.9
Belhar   47   0.9  13.8
Delft 142 16.7  12.8
Bishop Lavis   68 0.01  20.3
Elsiesrivier 148   1.7  12.6
Bellville-Suid   42   9.4    8.9
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